Terms ending in 2029
Every in-force patent on Baxalta Incorporated's record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,399,249 | Procedure for the Generation of a High Producer Cell Line for the Expression of a Recombinant ANTI-CD34 Antibody In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 10,233,436 | ADAMTS13-Containing Compositions Having Thrombolytic Activity In force · Medium confidence | Takeda Pharmaceutical Company Limited | In force | Medium confidence | |
| US 9,206,234 | Biologically Active Peptides In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 10,287,319 | Biologically Active Peptides In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 8,399,632 | Method for the Purification of Recombinant Blood Coagulation Factor IX Enriched in Sulfated And/Or Phosphorylated Molecules In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 8,022,187 | Fviii-Independent Fix-Mutant Proteins for Hemophilia a Treatment In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 8,962,549 | Polymeric Benzyl Carbonate-Derivatives In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 10,232,022 | Lyophilized Recombinant VWF Formulations In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 10,512,674 | Factor VIII Formulations In force · Medium confidence | Takeda Pharmaceutical Company Limited | In force | Medium confidence | |
| US 11,020,459 | Factor VIII Formulations In force · Medium confidence | Takeda Pharmaceutical Company Limited | In force | Medium confidence | |
| 6 more term ends in 2029 · Pro | |||||
10 of 16 patents shown. Soonest term end first, then patent number.
Pro members see all 16.
1 of these is in force and held by Baxalta Incorporated.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.